Your browser doesn't support javascript.
loading
Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?
Carter, Philip; Alifrangis, Costi; Cereser, Biancastella; Chandrasinghe, Pramodh; Belluz, Lisa Del Bel; Herzog, Thomas; Levitan, Joel; Moderau, Nina; Schwartzberg, Lee; Tabassum, Neha; Wen, Jinrui; Krell, Jonathan; Stebbing, Justin.
Affiliation
  • Carter P; Department of Surgery and Cancer, Imperial College, London, UK.
  • Alifrangis C; Department of Oncology, University College Hospital, London, UK.
  • Cereser B; Department of Surgery and Cancer, Imperial College, London, UK.
  • Chandrasinghe P; Department of Surgery and Cancer, Imperial College, London, UK.
  • Belluz LDB; Department of Surgery, University of Kelaniya, Kelaniya, Sri Lanka.
  • Herzog T; Department of Surgery and Cancer, Imperial College, London, UK.
  • Levitan J; Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati, USA.
  • Moderau N; University of Cincinnati Cancer Institute, University of Cincinnati, Cincinnati, USA.
  • Schwartzberg L; Department of Surgery and Cancer, Imperial College, London, UK.
  • Tabassum N; Department of Surgery and Cancer, Imperial College, London, UK.
  • Wen J; WEST Cancer Center, The University of Tennessee, Memphis, USA.
  • Krell J; Department of Surgery and Cancer, Imperial College, London, UK.
  • Stebbing J; Department of Surgery and Cancer, Imperial College, London, UK.
Oncotarget ; 9(10): 9456-9467, 2018 Feb 06.
Article in En | MEDLINE | ID: mdl-29507702

Full text: 1 Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: Oncotarget Year: 2018 Type: Article Affiliation country: United kingdom

Full text: 1 Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: Oncotarget Year: 2018 Type: Article Affiliation country: United kingdom